1	Transfusión	transfusión	NCFS000	C0086818_1	procedimiento_1	0-11	219_ANS_clinical_caseMIR	SENT1	-	-
2	de	de	SPS00	C0086818_2	procedimiento_2	12-14	219_ANS_clinical_caseMIR	SENT1	-	-
3	plaquetas	plaqueta	NCFP000	C0086818_3	procedimiento_3	15-24	219_ANS_clinical_caseMIR	SENT1	B-Estructura_Corporal	-
4	.	.	Fp	-	-	24-25	219_ANS_clinical_caseMIR	SENT1	-	-

1	Rituximab	rituximab	NC00SC0	C0393022	producto#sustancia	0-9	219_ANS_clinical_caseMIR	SENT2	B-Grp_Medicamento	-
2	en	en	SPS00	C1720294#C0332285	calificador#atributo	10-12	219_ANS_clinical_caseMIR	SENT2	-	-
3	pauta	pauta	NCFS000	-	-	13-18	219_ANS_clinical_caseMIR	SENT2	-	-
4	semanal	semanal	AQ0CS0	C0332174	calificador	19-26	219_ANS_clinical_caseMIR	SENT2	-	-
5	.	.	Fp	-	-	26-27	219_ANS_clinical_caseMIR	SENT2	-	-

1	Ciclofosfamida	ciclofosfamida	NCFS000	C0010583	producto#sustancia	0-14	219_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
2	en	en	SPS00	C1720294#C0332285	calificador#atributo	15-17	219_ANS_clinical_caseMIR	SENT3	-	-
3	pulsos	pulso	NCMP000	C0391850	función	18-24	219_ANS_clinical_caseMIR	SENT3	-	-
4	de	de	SPS00	C0332285	atributo	25-27	219_ANS_clinical_caseMIR	SENT3	-	-
5	4	4	Z	-	-	28-29	219_ANS_clinical_caseMIR	SENT3	-	-
6	días	d	NCMP000	-	-	30-34	219_ANS_clinical_caseMIR	SENT3	-	-
7	cada	cada	NC00SC0	C1457900	calificador	35-39	219_ANS_clinical_caseMIR	SENT3	-	-
8	21	21	Z	-	-	40-42	219_ANS_clinical_caseMIR	SENT3	-	-
9	días	d	NCMP000	-	-	43-47	219_ANS_clinical_caseMIR	SENT3	-	-
10	Plasmaferesis	plasmaferesis	NCFN000	-	-	0-13	219_ANS_clinical_caseMIR	SENT3	B-Grp_Medicamento	-
11	diaria	diario	AQ0FS0	C0332173	calificador	14-20	219_ANS_clinical_caseMIR	SENT3	-	-
12	.	.	Fp	-	-	20-21	219_ANS_clinical_caseMIR	SENT3	-	-

1	Prednisona	prednisona	NCFS000	C0032952	sustancia	0-10	219_ANS_clinical_caseMIR	SENT4	B-Grp_Medicamento	-
2	a	a	SPS00	-	-	11-12	219_ANS_clinical_caseMIR	SENT4	-	-
3	1	1	Z	-	-	13-14	219_ANS_clinical_caseMIR	SENT4	-	-
4	mg	mg	NCMN000	-	-	15-17	219_ANS_clinical_caseMIR	SENT4	-	-
5	/	/	Fh	-	-	17-18	219_ANS_clinical_caseMIR	SENT4	-	-
6	dia	dia	NC00YL0	-	-	18-21	219_ANS_clinical_caseMIR	SENT4	-	-
7	durante	durante	SPS00	C1444752#C0347984	atributo	22-29	219_ANS_clinical_caseMIR	SENT4	-	-
8	2-3	2-3		-	-	30-33	219_ANS_clinical_caseMIR	SENT4	-	-
9	semanas	semana	NCFP000	C0439230	calificador	34-41	219_ANS_clinical_caseMIR	SENT4	-	-
10	.	.	Fp	-	-	41-42	219_ANS_clinical_caseMIR	SENT4	-	-

